Table 2a

Application to the MSAC and Duration of Assessment

App.
Description
First MSAC Meeting
MSAC Meeting – Endorsed
Minister Sign Off
Duration in Months
MSAC Outcome

1001
Advanced breast biopsy instrumentation
May'98

May'99
12
Negative
1002
Oto-acoustic emission audiometry
May'98

Aug'99
15
Positive
1003
OctreoScan¨ scintigraphy for gastro-entero-pancreatic neuroendocrine tumours
May'98

Aug'99
15
Positive
1004
Transmyocardial laser revascularization
May'98
Aug'99
Sept'99
16
Negative
1005
Visual electrodiagnosis
May'98
May'01
Jun'01
25
Partial
1006
Endoluminal grafting for abdominal aortic aneurysm
May'98

May'99
12
Partial
1007
Saline infusion sonohysterography
May'98

May'99
12
Positive
1008
Photodynamic therapy for skin and mucosal cancer
May'98

May'99
12
Negative
1009
Sacral nerve stimulation for urinary incontinence
May'98

Mar'00
22
Negative
1010
Intravascular extraction of chronically implanted permanent transvenous pacing leads
Sept'98
Aug'99
Sept'99
12
Positive
1011
Lung volume reduction surgery – for advanced emphysema
Sept'98
Feb'01
Apr'01
19
Negative
1012
Vertebral axial decompression therapy for chronic back pain
Feb'99
May'01
Jun'01
28
Negative
1013
Treatment of diseases of the inner ear using the Round Window Microcath System
Aug'99


-
Ineligible
1014
TransUrethral Needle Ablation for benign prostatic hyperplasia
May'99
Nov'01/Mar'02
May'02
36
Interim
1015
Directional, vacuum-assisted breast biopsy
May'98
Aug'99
Sept'99
16
Interim
1016
Samarium153-lexidronam for bone pain due to skeletal metastases
May'98

Aug'99
15
Positive
1017
Chelation therapy – for cardiovascular disease
Nov'98


-
Ineligible
1018–1020
Hyperbaric oxygen treatment
May'99

Feb'01
21
Partial
1022
Commercial-in-Confidence Application
May'99


-
Ineligible
1023
Placement of artificial bowel sphincters in the management of faecal incontinence
May'99
Nov'99
Nov'99
12
Negative
1024
Total ear reconstruction
May'99

Mar'00
10
Positive
1025
Provision of Positron Emission Tomography (PET) services – deferred. See Reference 02
Aug'99

Aug'00
12
Ref 02
1026
Near patient cholesterol testing using the Cholestech LDX
Aug'99
Aug'01
Sept'01
25
Interim
1027
Provision of Positron Emission Tomography (PET) services – deferred. See Reference 02
Aug'99


-
Ref 02
1028
Gamma knife surgery
Nov'99
Nov'00
Aug'01
21
Negative
1029
Brachytherapy for the treatment of prostate cancer
Nov'99
Nov'00
Feb'01
15
Interim
1030
Low intensity ultrasound treatment for the acceleration of bone fracture healing – Exogen\texttrademark bone growth stimulator
Feb'00
Nov'01
Feb'02
24
Negative
1031
Deep brain stimulation for symptoms of advanced Parkinson's disease
May'00
May'01
Jun'01
13
Interim
1032
Intravascular ultrasound
May'00
Mar'02
May'02
24
Negative
1033
Autogenous cartilage implantation
May'00


?
On hold
1034
Selective Internal Radiation Therapy for hepatic Metastases using SIR-Spheres®
May'00
Nov'01/Mar'02
Aug'02
27
Negative
1035
Genetic test for Fragile X syndrome
May'00
Mar'02
Aug'02
27
Positive
1036
Percutaneous transluminal coronary rotational atherectomy for lesions of the coronary arteries
Aug'00

Sept'02
25
Partial
1037
Advanced breast biopsy instrumentation (Note earlier application 1001)
Aug'00
Aug'01
Sept'01
13
Positive
1038
Conformal radiotherapy
Aug'00
Nov'01
Feb'02
18
Positive
1039
Photodynamic therapy with verteporfin for macular degeneration
Nov'00
Aug'01
Sept'01
10
Partial
1040
Anatomical biomodelling
Nov'00


-
Ineligible
1041
Intravascular Brachytherapy – Commercial-in-Confidence application
May'01
Aug'02
Oct'02
17
Interim
1042
Cardiac resynchronisation therapy (CRT)
May'01
Aug'05

55+
Positive
1043
Thyrogen\texttrademark (thyrotropin alfa) as a diagnostic agent for well-differentiated thyroid cancer
May'01
Aug'02
Oct'02
17
Negative
1044
Ostase immunoassay for the mass measurement of serum bone alkaline phosphatase
May'01
May'03
Aug'03
27
Negative
1045
Intra-articular viscosupplementation for treatment of osteoarthritis of the knee
Aug'01

Mar'03
19
Negative
1046
Interstim for sacral nerve stimulation in patients with refractory urinary incontinence
Aug'01
Jun'02

11+
Negative
1047
Endoluminal Gastroplication for the treatment of Gastro-Oesophageal Reflux Disease GORD
Aug'01

Jun'02
10
Negative
1048
Intradiscal electrothermal anuloplasty for patients with chronic low back pain due to anular disruption of contained herniated discs
Aug'01
Nov'02
Dec'02
16
Negative
1049
M-VAX TM – a treatment for patients with advanced stage III melanoma
Nov'01
Aug'02
Oct'02
11
Negative
1050
Optical Biometry
Nov'01
Mar'03/Aug'03
Jun'04
31
Positive
1051
Vacuum Assisted Closure (VAC) Therapy
Nov'01


-
Ineligible
1052
Radiofrequency ablation of liver tumours
Nov'01
May'03
Aug'03
21
Partial
1053
Placement of artificial bowel sphincters in the management of faecal incontinence
Mar'02
May'03
?
14+
Negative
1054
Hyperbaric Oxygen Therapy (Resubmission)
Mar'02
May'03/Aug'03
Aug'04
29
Interim
1055
Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants
Mar'02
Nov'03
Mar'05
36
Negative
1056
LeukoScan®
May'02
May'03
Aug'03
15
Partial
1057
M2A® capsule endoscopy – evaluation of obscure gastrointestinal bleeding in adult patients
Aug'02
Aug'03
Sept'03
16
Interim
1058
QuantiFERON-TB Gold

Aug'04

-
Withdrawn
1059
Endo Venous Laser Treatment for Varicose Veins
Mar'03
Nov'03
Aug'04
17
Negative
1060
Bone Mineral Densitometry – Reference 19
Mar'03
Nov'04

-
Withdrawn
1061
Implantation of Insertable Loop Recorder for Diagnosis of Recurrent Unexplained Syncope
Mar'03
Nov'03

8+
Positive
1062
A scan for Imaging Recurrence and/or metastases in patients with histologically demonstrated carcinoma of the colon or rectum
Mar'03
May'04
Aug'04
17
Negative
1063
Photodynamic Therapy for Verteporfin (Visudyne) for Subfoveal choroidal neovasculanisations (Commercial in Confidence)
Mar'03
Nov'03
Mar'05
24
Unchanged
1064
Three dimensional magnetic electroanatomical radiofrequency ablation for the treatment of cardiac arrhythmia's
Mar'03


-
Ineligible
1065
Sentinel Node Biopsy for Breast Cancer
Mar'03
Mar'05
Jul'05
28
Interim
1066
Drug (Sirolimus) Eluting Stents ("Commercial-in-Confidence") – Refer to Reference 21
Mar'03
Aug'03
Sept'03
-
Ref 21
1067
Genotypic resistance testing of antiretrovirals in HIV
Aug'03
Aug'04
Mar'05
19
Negative
1068
Prostate specific antigen (PSA) test
Mar'04
Mar'05
Jul'05
16
Unchanged
1069
Endoscopic ultrasound for the pre-operative staging of gastric and oesophageal neoplasms – Refer to Application 1072
Mar'04


21+
App 1072
1070
An innovative patent for tobacco smoking cessation
Mar'04


-
Ineligible
1071
Measurement of international normalised ratio (INR) in general practice
Mar'04
May'05
Jul'05
16
Negative
1072
Endoscopic ultrasound for staging pancreatic, gastric, oesophageal and hepato-biliary neoplasms
Mar'04


21+
Incomplete
1073
METVIX (Commercial-in-confidence) – referred to the PBAC
Mar'04



Withdrawn
1074
Freelight Lambda and Freelight Kappa
Mar'04


-
Withdrawn
1075
Endoscopic ultrasound for the diagnosis and pre-operative staging of Hepato-biliary neoplasms – Refer to Application 1072
Mar'04


21+
Incomplete
1076
Transurethral microwave thermotherapy (TUMT)
May'04


19+
Positive
1077
Sacral nerve stimulation for faecal incontinence
May'04
May'05
Jul'05
14
Positive
1078
Multifocal multichannel objective perimetry (MMOP)
May'04
Aug'04

3+
Negative
1079
Peripheral arterial tonometry with ascending aortic waveform analysis using the SphygmoCor system
May'04
Mar'06

19+
Incomplete
1080
Radi pressure wire
Aug'04
Nov'05

16+
Incomplete
1081
Uterine artery embolisation
Aug'04


16+
Incomplete
1082
SIR-Spheres® for the treatment of non-resectable liver tumours
Aug'04


11+
Interim
1083
Intac Implants
Aug'04


11+
Negative
1084
Uro Vysion
Aug'04
Nov'05

16+
Incomplete
1085
Carbon labelled urea breath test
Nov'04


13+
Incomplete
1087
B-Type Natriuretic Peptide – includes 1086
Aug'04


16+
Incomplete
1089
Brachytherapy for the treatment of prostate cancer
Nov'04
May'05
Jul'05
8
Interim
1090
Artificial intervertebral disc replacement – previously Reference 29
Mar'04
Nov'05

14+
Incomplete
1091
Minimally Invasive Robotic Assisted Radical Prostatectomy
Mar'05


9+
Incomplete
1092
Deep brain stimulation for the symptoms of Parkinson's disease
Mar'05


9+
Incomplete
1093
Endovascular Neurointerventional Procedures
Mar'05


9+
Incomplete

Source: MSAC Web Site: http://www7.health.gov.au/msac/ – Accessed 6th Jan'06 Correct as at end Dec'05

O'Malley Australia and New Zealand Health Policy 2006 3:3   doi:10.1186/1743-8462-3-3